国联安中证医药100C(006569)
2025-05-21
0.9756
0.5773%
| 报告期 |
证券买卖差价收入 |
投资收益 |
回购收入 |
其他收入 |
合计 |
| 2024-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | -2,483.14 |
| 2024-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | -4,183.00 |
| 2023-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | -2,491.76 |
| 2023-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | -1,800.45 |
| 2022-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | -3,769.56 |
| 2022-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | -2,856.35 |
| 2021-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 7,532.30 |
| 2021-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 9,303.63 |
| 2020-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 89,567.61 |
| 2020-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 77,593.30 |
| 2019-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 44,776.59 |
| 2019-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 24,966.12 |
| 2018-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | -39,553.11 |
